Protagonist Therapeutics (PTGX) PT Raised to $190 at BMO Capital
Tweet Send to a Friend
(Updated - September 1, 2026 9:09 AM EDT)
BMO Capital analyst Evan David Seigerman raised the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital analyst Evan David Seigerman raised the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
